Related Experiment Video
Updated: May 5, 2026

Toxicological Assays for Testing Effects of an Epigenetic Drug on Development, Fecundity and Survivorship of Malaria Mosquitoes
Published on: January 16, 2015
A population physiologically based kinetic and toxicodynamic model for acute diazinon exposure
Jiaqi Chen1, Bingxu Chen1, Sebastiaan Wesseling1
1Division of Toxicology, Wageningen University and Research, Stippeneng 4, Wageningen, Gelderland 6708 WE, the Netherlands.
Abstract:
Organophosphate (OP) pesticide residues are frequently found in the environment and food products, with their acute exposures to humans posing a risk of neurotoxicity through acetylcholinesterase (AChE) inhibition. The aim of the present study is to develop a New Approach Methodology (a population-based physiologically based kinetic and toxicodynamic (PBK-TD) model) to define a health-based guidance value (HBGV) for acute exposure to diazinon as the model OP, taking into account human interindividual variability in physiology, toxicokinetics and toxicodynamics. Physiological and chemical-specific inputs for the PBK-TD model were obtained from literature or by in silico-in vitro strategies. Using this population model and Monte Carlo simulations, the dose-dependent response for DZN-induced erythrocyte AChE inhibition was generated to provide a point of departure (POD) for defining an acute reference dose (ARfD). The model simulates the toxicokinetic and toxicity data observed in humans well, and results reveal that toxicokinetic and not toxicodynamic variations are the main driver of the overall interindividual variability in susceptibility towards acute DZN exposure. The POD predicted for the sensitive adults is in agreement with a previously reported human no-observed-adverse-effect level (NOAEL). It is concluded that the population PBK-TD modeling defines a novel way to derive a POD for human health risk assessment with the incorporation of interindividual differences. In the next step, the inclusion of correlations between certain model parameters as well as cholinesterase inhibition in tissues other than the blood is expected to be a further refinement.
More Related Videos
Related Concept Videos
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Pharmacokinetic–Pharmacodynamic Relationship: Exposure, Response and Effect
Pharmacokinetic–Pharmacodynamic Relationship: Model Components
Pharmacodynamic Models: Overview
Pharmacodynamic Models: Direct Effect Model and Indirect Response Model
Toxicity Testing in Animals

